Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on…
Pharmaceuticals, Biotechnology and Life Sciences
REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on…
WATERTOWN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…
Maggie A. Pax Maggie A. Pax Appointed to Board of Directors of Alimera Sciences ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE)…
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer…
– First fiscal quarter revenue and government support income increased 191% year-over-year and 88% sequentially due to strong organic growth…
Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2…
Press release Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum…
— Phase 2 Data for Potentially the First Oral Therapeutic for PGHD Met All Primary and Secondary Endpoints with Supportive…
ROCKVILLE, Md., Nov. 07, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
Reiterates commencement of pivotal pharmacokinetic (PK) study for Anaphylmâ„¢ (epinephrine) Sublingual Film expected in fourth quarter 2023 with topline data…